Enovix Corp Files 8-K: Reg FD, Financials

Ticker: ENVX · Form: 8-K · Filed: 2025-09-09T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure, financials

Related Tickers: ENVX

TL;DR

Enovix filed an 8-K on Sept 9th covering Reg FD and financials. Address is 3501 W Warren Ave, Fremont, CA.

AI Summary

Enovix Corporation filed an 8-K on September 9, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 3501 W. Warren Avenue, Fremont, California, 94538, and its principal business phone number as (510) 695-2350. The company was formerly known as Rodgers Silicon Valley Acquisition Corp until a name change on October 14, 2020.

Why It Matters

This filing provides an update on Enovix Corporation's regulatory disclosures and financial reporting, which is important for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This is a routine filing for an 8-K, primarily containing disclosures and exhibit information without significant new financial events.

Key Players & Entities

FAQ

What specific Regulation FD disclosures are being made in this 8-K filing?

The filing indicates a Regulation FD Disclosure is part of the report, but the specific details of the disclosure are not provided in the provided text snippet.

What financial statements or exhibits are included with this 8-K filing?

The filing states that 'Financial Statements and Exhibits' are included, but the specific list or content of these documents is not detailed in the provided text.

What is Enovix Corporation's primary business address?

Enovix Corporation's principal executive offices are located at 3501 W. Warren Avenue, Fremont, California, 94538.

When did Enovix Corporation change its name from Rodgers Silicon Valley Acquisition Corp?

The company changed its name from Rodgers Silicon Valley Acquisition Corp on October 14, 2020.

What is the Commission File Number for Enovix Corporation?

The Commission File Number for Enovix Corporation is 001-39753.

Filing Stats: 553 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2025-09-09 06:40:24

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Following the conclusion of its warrant dividend financing, Enovix Corporation updated its investor presentation furnished with this Current Report as Exhibit 99.1. Exhibit 99.1 is incorporated into this Item 7.01 by reference. The information furnished in this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and shall not be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Investor Presentation dated September 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Enovix Corporation Date: September 9, 2025 By: /s/ Arthi Chakravarthy Arthi Chakravarthy Chief Legal Officer and Head of Corporate Development

View on Read The Filing